We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTVA icon
401
Corteva
CTVA
$60.5B
$4.44M 0.03%
75,619
+31,944
+73% +$2.02M
HPQ icon
402
HP
HPQ
$26B
$4.43M 0.03%
164,793
-350,318
-68% -$9.7M
SPG icon
403
Simon Property Group
SPG
$76.4B
$4.39M 0.03%
37,360
-8,726
-19% -$970K
TGNA
404
DELISTED
TEGNA Inc
TGNA
$4.31M 0.03%
203,388
+9,348
+5% +$188K
XYZ
405
Block Inc
XYZ
$48.9B
$4.3M 0.03%
68,426
-4,557
-6% -$281K
PLUG icon
406
Plug Power
PLUG
$2.65B
$4.29M 0.03%
347,011
+262,258
+309% +$4.18M
ANET icon
407
Arista Networks
ANET
$199B
$4.25M 0.03%
140,024
-18,564
-12% -$571K
PAYX icon
408
Paychex
PAYX
$43.4B
$4.24M 0.03%
36,676
+3,653
+11% +$428K
PEN icon
409
Penumbra
PEN
$12.6B
$4.24M 0.03%
19,047
+13,209
+226% +$2.58M
WDAY icon
410
Workday
WDAY
$41.5B
$4.22M 0.03%
25,237
-2,864
-10% -$447K
SWTX
411
DELISTED
SpringWorks Therapeutics
SWTX
$4.22M 0.03%
162,109
COF icon
412
Capital One
COF
$128B
$4.2M 0.03%
45,233
-39
-0.1% -$3.83K
RGA icon
413
Reinsurance Group of America
RGA
$15.5B
$4.17M 0.03%
+29,350
New +$4.1M
OKTA icon
414
Okta
OKTA
$23.8B
$4.15M 0.03%
60,748
-79,980
-57% -$4.57M
GATX icon
415
GATX Corp
GATX
$6.45B
$4.13M 0.03%
38,853
-12,296
-24% -$1.28M
IRBT
416
DELISTED
iRobot
IRBT
$4.07M 0.03%
84,605
-65,969
-44% -$3.49M
KMI icon
417
Kinder Morgan
KMI
$70.9B
$4.07M 0.03%
224,952
+29,549
+15% +$531K
LNG icon
418
Cheniere Energy
LNG
$54.2B
$4.05M 0.03%
27,030
+7,145
+36% +$1.2M
EOG icon
419
EOG Resources
EOG
$77.7B
$4.05M 0.03%
31,256
+694
+2% +$92.3K
DOC icon
420
Healthpeak Properties
DOC
$15.5B
$3.96M 0.03%
158,149
-46,053
-23% -$1.12M
ITRI icon
421
Itron
ITRI
$4.54B
$3.96M 0.03%
78,181
-15,091
-16% -$746K
NEM icon
422
Newmont
NEM
$96.2B
$3.96M 0.03%
83,801
-4,539
-5% -$203K
VMW
423
DELISTED
VMware, Inc
VMW
$3.94M 0.03%
32,061
-12,537
-28% -$1.45M
BAX icon
424
Baxter International
BAX
$12.8B
$3.91M 0.03%
76,706
-8,828
-10% -$474K
WAT icon
425
Waters Corp
WAT
$37.3B
$3.89M 0.03%
11,352
-1,031
-8% -$326K

Similar funds

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.